TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INCREASE IN THE GERIATRIC POPULATION
4.1.2 RISING INCIDENCE OF GLAUCOMA ACROSS THE WORLD
4.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT PREVENTION OF BLINDNESS
4.1.4 GROWING POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE
4.2 RESTRAINTS
4.2.1 INADEQUATE REIMBURSEMENT SCENARIO
4.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
4.2.3 HIGH COST OF SURGICAL PROCEDURES
4.3 OPPORTUNITIES
4.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
4.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
?
4.4 CHALLENGES
4.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
4.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY
5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 MIGS STENTS
5.3 MIGS SHUNTS
5.4 OTHERS
6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
6.1 OVERVIEW
6.2 TRABECULAR MESHWORK
6.3 SUPRACHOROIDAL SPACE
6.4 SUBCONJUNCTIVAL FILTRATION
6.5 REDUCING AQUEOUS PRODUCTION
7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
7.1 OVERVIEW
7.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
7.3 STAND-ALONE GLAUCOMA
8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITAL OUTPATIENT DEPARTMENTS (HOPD)
8.3 OPHTHALMOLOGY CLINICS
8.4 AMBULATORY SURGERY CENTERS (ASCS)
8.5 OTHERS
9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DIRECT TENDER
9.3 RETAIL SALES
10 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GEOGRAPHY
10.1 EUROPE
10.1.1 GERMANY
10.1.2 FRANCE
10.1.3 U.K.
10.1.4 ITALY
10.1.5 SPAIN
10.1.6 SWITZERLAND
10.1.7 NETHERLANDS
10.1.8 BELGIUM
10.1.9 RUSSIA
10.1.10 TURKEY
10.1.11 REST OF EUROPE
11 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
12 COMPANY PROFILE
12.1 GLAUKOS CORPORATION
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 ALLERGAN
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 IVANTIS, INC.
12.3.1 COMPANY SNAPSHOT
12.3.2 COMPANY SHARE ANALYISIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENTS
?
12.4 ELLEX
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 ALCON
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 BVI
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 MICROSURGICAL TECHNOLOGY (A SUBSIDIARY OF HALMA PLC)
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENTS
12.9 MOLTENO OPHTHALMIC LTD
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.10 NEW WORLD MEDICAL, INC.
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 SANTEN PHARMACEUTICAL CO., LTD.
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 TECHNOLOGY PORTFOLIO
12.11.4 RECENT DEVELOPMENT
?
12.12 SIGHT SCIENCES
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENT
13 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS
13.1 SWOT: ANALYSIS
13.1.1 STRENGTH: - STRONG EUROPE PRESENCE
13.1.2 WEAKNESS: - DEPENDENCE ON THIRD PARTY SUPPLIERS/CONTRACTORS
13.1.3 OPPORTUNITIES: - INCREASED RESEARCH AND DEVELOPMENT ACTIVITIES
13.1.4 THREAT: - FOREIGN CURRENCY CONVERSION RISKS
13.2 DATA BRIDGE MARKET RESEARCH ANALYSIS
14 CONCLUSION
15 QUESTIONNAIRE
16 RELATED REPORTS